Evolutionary Genomics, Inc. financial data

Industry
Services-Commercial Physical & Biological Research
Location
4220 Morningstar Drive, Castle Rock, Colorado
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Fona, Inc. (to 10/21/2015)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 929 % +48.1%
Debt-to-equity -77.4 % +16.7%
Return On Equity 38.9 % -53.9%
Return On Assets -66.5 % +20.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares +0.61%
Common Stock, Shares, Outstanding 6.66M shares +13.1%
Entity Public Float 3.14M USD -32.3%
Common Stock, Value, Issued 6.66K USD +13.1%
Weighted Average Number of Shares Outstanding, Basic 6.46M shares +9.81%
Weighted Average Number of Shares Outstanding, Diluted 6.46M shares +9.81%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 417K USD -66.2%
General and Administrative Expense 1.25M USD -1.58%
Operating Income (Loss) -2.01M USD +30%
Nonoperating Income (Expense) 79.3K USD -5.55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.93M USD +30.7%
Net Income (Loss) Attributable to Parent -1.93M USD +30.7%
Earnings Per Share, Basic -0.35 USD/shares +32.7%
Earnings Per Share, Diluted -0.35 USD/shares +32.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 577K USD +170%
Assets, Current 699K USD +173%
Property, Plant and Equipment, Net 3.96K USD -78.8%
Assets 2.35M USD -19.7%
Liabilities, Current 159K USD +300%
Liabilities 3.92M USD +4.24%
Retained Earnings (Accumulated Deficit) -19.8M USD -10.8%
Stockholders' Equity Attributable to Parent -5.59M USD -27.1%
Liabilities and Equity 2.35M USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -641K USD +59.5%
Net Cash Provided by (Used in) Financing Activities 1M USD -36.5%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 780M shares 0%
Common Stock, Shares, Issued 6.66M shares +13.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 577K USD +170%
Deferred Tax Assets, Valuation Allowance 3.19M USD +12.4%
Depreciation 14.7K USD -54%
Property, Plant and Equipment, Gross 504K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 2.93M USD +1.8%
Preferred Stock, Shares Authorized 20M shares 0%
Depreciation, Depletion and Amortization 1.02M USD -1.67%
Deferred Tax Assets, Net of Valuation Allowance 309K USD -52.6%
Share-based Payment Arrangement, Expense 78.2K USD +42.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%